Dr. S.0 MIKAYE/LinkedIn
Dec 20, 2025, 12:17
VTE Risks, Clinical Features, Diagnosis and Management Explained by Samwel Mikaye
Samwel Mikaye, CEO of SaMik Medical Center, posted on LinkedIn:
“Venous Thromboembolism (VTE) refers to the formation of a blood clot in the venous system. It includes:
- Deep Vein Thrombosis (DVT) – clot usually in deep veins of the leg
- Pulmonary Embolism (PE) – clot travels to and blocks pulmonary arteries

Risk factors (Virchow’s triad)
1. Venous stasis
- Prolonged immobility, bed rest
- Long travel
- Heart failure
2. Endothelial injury
- Surgery (especially orthopedic)
- Trauma
- Central venous catheters
3. Hypercoagulability
- Pregnancy & postpartum
- Malignancy
- Oral contraceptives
- Inherited thrombophilias
Clinical features
Deep Vein Thrombosis (DVT)
- Unilateral leg swelling
- Pain or tenderness
- Warmth and redness
- Increased calf circumference
Pulmonary Embolism (PE)
- Sudden shortness of breath
- Chest pain (pleuritic)
- Tachycardia
- Cough ± hemoptysis
- Syncope (severe cases)
Diagnosis
DVT
- Wells score
- D-dimer (screening)
- Compression ultrasound (confirmatory)
PE
- CT pulmonary angiography (CTPA) – gold standard
- D-dimer (low-risk patients)
- V/Q scan (when CTPA contraindicated)
Management
Acute treatment
- Anticoagulation
- Low Molecular Weight Heparin (LMWH)
- Unfractionated heparin
- Direct Oral Anticoagulants (DOACs)
- Warfarin (with heparin bridge)
Severe / life-threatening PE
- Thrombolysis
- Surgical or catheter embolectomy
Prevention (VTE prophylaxis)
- Early mobilization
- Compression stockings
- Intermittent pneumatic compression
- Prophylactic anticoagulation (LMWH)
Complications
- Recurrent VTE
- Post-thrombotic syndrome
- Chronic thromboembolic pulmonary hypertension (CTEPH)”
Get the latest from Hemostasis Today.
-
Apr 6, 2026, 16:39Dhinesh Selvaraju: FDA Approves Narsoplimab (Yartemlea) as 1st Treatment for TA-TMA in Adults and Children
-
Apr 6, 2026, 16:38Linda Vorberg: A Detailed Analysis on The Usefulness of CT for DL-Based Stroke Lesion Segmentation
-
Apr 6, 2026, 16:37Colleen Hearn: Telestroke Helps Resource-Limited Facilities Gain Access to Unavailable Expertise
-
Apr 6, 2026, 16:37Nicolas Hubacz: AI Maps Neuroplasticity in Stroke Recovery – How the Brain Adapts After Injury
-
Apr 6, 2026, 16:36Cristina de Diego Alonso: Movement Is Not Just an Exercise, It Is The Rhythm of Daily Life
-
Apr 6, 2026, 16:35Charles Okyere Boadu: What Is The Most Likely Cause of Persistent Thrombocytopenia Despite Transfusion?
-
Apr 6, 2026, 16:34Tumor Mutations and VTE Risk – New Insights from a 12,500-Patient Cancer Study – JTH
-
Apr 6, 2026, 16:31Wolfgang Miesbach: New Real-World Data Reveal Ongoing Burden in Moderate-to-Severe Haemophilia A
-
Apr 6, 2026, 16:26Heghine Khachatryan։ Targeting High Risk Antiphospholipid Syndrome in Pregnancy with Hydroxychloroquine